Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Pidilizumab (Anti-PDCD1 / PD-1 / CD279) For research use only.
Not for use in humans.

Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: CT 011

Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Pidilizumab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Product Details

CAS No. 1036730-42-3
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Pidilizumab (Anti-PDCD1 / PD-1 / CD279) | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Pidilizumab (Anti-PDCD1 / PD-1 / CD279) | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) cost | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Pidilizumab (Anti-PDCD1 / PD-1 / CD279) | Pidilizumab (Anti-PDCD1 / PD-1 / CD279) distributor